![ATS 2024 logo](https://www.mediartx.com/wp-content/uploads/2024/05/ATS-2024-logo.png)
2024
Gabriela Dower, et al
Anti-WISP1 (MTX-463) as a Novel Potential Therapy for Idiopathic Pulmonary Fibrosis
Presented at The American Thoracic Society International Conference
![Ephrin Congress logo](https://www.mediartx.com/wp-content/uploads/2024/05/Ephrin-Congress-logo.png)
2024
Benjamin T. Wilks, et al
Anti-EphrinB2 neutralizing antibody suppresses fibrosis in preclinical in vitro and in vivo models
Presented at The 4th Congress on the EPH/Ephrins System
![Keystone Symposia logo](https://www.mediartx.com/wp-content/uploads/2023/03/KeystoneSymposia-logo-e1679317796542.png)
2023
BM Kim et al
WISP1 Neutralization Suppresses Fibrosis in Preclinical in vivo and ex vivo Models
Presented at the Keystone Symposia on Fibrosis Pathogenesis and Resolution: From Mechanism to Therapies
![](https://www.mediartx.com/wp-content/uploads/2023/03/aegean_main_logo.png)
2022
P Yaworsky et al
miR-15a Reprograms Activated Hepatic Stellate Cells Back Towards Quiescence by Targeting WISP1.
Presented at the 3rd International Conference on Tissue Repair, Regeneration, and Fibrosis
![](https://www.mediartx.com/wp-content/uploads/2023/10/nature-medicine-logo.png)
2017
David Lagares et al
ADAM10-mediated ephrin-B2 shedding promotes myofibroblast activation and organ fibrosis
Nature Medicine